International Business Machines Corp vs Liquidia Corporation Common Stock — how do they compare? International Business Machines Corp trades at $226.56 (market cap $214.69B), while Liquidia Corporation Common Stock trades at $34 (market cap $3.04B). The key difference: International Business Machines Corp is far larger — about 70.6× Liquidia Corporation Common Stock's market cap, and International Business Machines Corp pays a 2.97% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 89 Days and Liquidia Corporation Common Stock for 0 Days on average.
| IBM | LQDA | |
|---|---|---|
Market Cap | $214.69B | $3.04B |
Volume | 4,038,637 | 21,111,778 |
Sector | Technology | Health |
52-Week High | $329.23 | $91.03 |
52-Week Low | $205.77 | $22.02 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $271.83B | $2.94B |
Dividend Yield | 2.97% | — |
Signals from Pluang's Aura AI — not financial advice
IBM stock trades at $230.78, up 1.66% with recent momentum driven by positive consulting sector sentiment and the launch of self-hosted deployment for its Bob AI platform. The company shows strong fundamentals with 2025 revenue of $67.54B and net income of $10.59B, though technical indicators signal bearish pressure. Recent earnings performance has been mixed with Q2 2026 missing expectations, while analyst consensus remains positive with a $255.50 price target.
IBM presents a balanced investment case with solid profitability metrics (15.52% net margin, 34.62% ROE) and growing AI consulting business ($5.5B book), but faces risks from cyclical mainframe weakness and competitive pressures. The stock trades at reasonable valuations (P/E 20.5) with upside potential if AI initiatives drive sustained growth.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →